Biomark Diagnostics Statistics
Total Valuation
BMKDF has a market cap or net worth of 37.13 million. The enterprise value is 36.59 million.
| Market Cap | 37.13M |
| Enterprise Value | 36.59M |
Important Dates
The next estimated earnings date is Thursday, February 26, 2026.
| Earnings Date | Feb 26, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 105.09M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +10.10% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 7.47% |
| Owned by Institutions (%) | n/a |
| Float | 53.55M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 419.00 |
| PB Ratio | 59.89 |
| P/TBV Ratio | 59.89 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -30.81 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -35.86 |
Financial Position
The company has a current ratio of 1.73, with a Debt / Equity ratio of 0.93.
| Current Ratio | 1.73 |
| Quick Ratio | 1.73 |
| Debt / Equity | 0.93 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.56 |
| Interest Coverage | -42.29 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -79.14% |
| Return on Invested Capital (ROIC) | -103.04% |
| Return on Capital Employed (ROCE) | -197.52% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.09 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +127.66% in the last 52 weeks. The beta is -0.21, so BMKDF's price volatility has been lower than the market average.
| Beta (5Y) | -0.21 |
| 52-Week Price Change | +127.66% |
| 50-Day Moving Average | 0.26 |
| 200-Day Moving Average | 0.21 |
| Relative Strength Index (RSI) | 62.90 |
| Average Volume (20 Days) | 11,094 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BMKDF had revenue of 88,606 and -1.19 million in losses. Loss per share was -0.01.
| Revenue | 88,606 |
| Gross Profit | 88,606 |
| Operating Income | -1.25M |
| Pretax Income | -1.19M |
| Net Income | -1.19M |
| EBITDA | -1.24M |
| EBIT | -1.25M |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 1.11 million in cash and 573,748 in debt, giving a net cash position of 535,903.
| Cash & Cash Equivalents | 1.11M |
| Total Debt | 573,748 |
| Net Cash | 535,903 |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 619,909 |
| Book Value Per Share | 0.01 |
| Working Capital | 522,448 |
Cash Flow
In the last 12 months, operating cash flow was -1.01 million and capital expenditures -8,435, giving a free cash flow of -1.02 million.
| Operating Cash Flow | -1.01M |
| Capital Expenditures | -8,435 |
| Free Cash Flow | -1.02M |
| FCF Per Share | n/a |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -1,413.46% |
| Pretax Margin | -1,340.24% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BMKDF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -10.10% |
| Shareholder Yield | -10.10% |
| Earnings Yield | -3.20% |
| FCF Yield | -2.75% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BMKDF has an Altman Z-Score of -1.06 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.06 |
| Piotroski F-Score | 2 |